HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $414 | – | 5 | +66.7% | 0.00% | – |
Q1 2022 | $0 | – | 3 | +200.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 1 | -93.3% | 0.00% | – |
Q4 2020 | $2,000 | – | 15 | +275.0% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 4 | -99.5% | 0.00% | – |
Q2 2020 | $67,000 | +42.6% | 748 | +58.8% | 0.00% | – |
Q1 2020 | $47,000 | -13.0% | 471 | 0.0% | 0.00% | – |
Q4 2019 | $54,000 | +5300.0% | 471 | +1245.7% | 0.00% | – |
Q2 2017 | $1,000 | -80.0% | 35 | -74.8% | 0.00% | – |
Q1 2016 | $5,000 | -16.7% | 139 | -30.5% | 0.00% | – |
Q3 2015 | $6,000 | +500.0% | 200 | +566.7% | 0.00% | – |
Q2 2015 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q1 2015 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q4 2014 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q3 2014 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q2 2014 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q1 2014 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q4 2013 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q3 2013 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q2 2013 | $1,000 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |